Park Avenue Securities’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.3M Sell
119,431
-3,656
-3% -$852K 0.19% 92
2026
Q1
$30.1M Buy
123,087
+13,046
+12% +$3.04M 0.24% 71
2025
Q4
$22.8M Buy
110,041
+23,337
+27% +$4.61M 0.19% 90
2025
Q3
$16.1M Buy
86,704
+2,303
+3% +$395K 0.13% 128
2025
Q2
$12.9M Sell
84,401
-15,906
-16% -$2.44M 0.12% 126
2025
Q1
$16.6M Buy
100,307
+22,768
+29% +$3.56M 0.2% 73
2024
Q4
$11.2M Sell
77,539
-4,748
-6% -$736K 0.12% 126
2024
Q3
$13.3M Buy
82,287
+10,664
+15% +$1.7M 0.15% 101
2024
Q2
$10.5M Buy
71,623
+22,681
+46% +$3.37M 0.13% 119
2024
Q1
$7.74M Buy
48,942
+1,476
+3% +$235K 0.1% 143
2023
Q4
$7.44M Buy
47,466
+2,074
+5% +$318K 0.1% 126
2023
Q3
$7.07M Buy
45,392
+6,948
+18% +$1.15M 0.11% 122
2023
Q2
$6.36M Buy
38,444
+1,198
+3% +$193K 0.1% 132
2023
Q1
$5.77M Buy
37,246
+1,459
+4% +$236K 0.1% 136
2022
Q4
$6.32M Buy
35,787
+1,298
+4% +$224K 0.11% 115
2022
Q3
$5.63M Buy
34,489
+3,696
+12% +$625K 0.11% 118
2022
Q2
$5.47M Buy
30,793
+3,209
+12% +$572K 0.11% 119
2022
Q1
$4.89M Buy
27,584
+2,394
+10% +$407K 0.09% 128
2021
Q4
$4.31M Buy
25,190
+3,245
+15% +$531K 0.08% 144
2021
Q3
$3.54M Sell
21,945
-5,645
-20% -$963K 0.07% 148
2021
Q2
$4.54M Buy
27,590
+323
+1% +$53.5K 0.1% 106
2021
Q1
$4.48M Buy
27,267
+2,365
+9% +$383K 0.11% 94
2020
Q4
$3.92M Sell
24,902
-522
-2% -$77K 0.11% 84
2020
Q3
$3.79M Buy
25,424
+1,576
+7% +$233K 0.13% 72
2020
Q2
$3.35M Buy
+23,848
New +$3.48M 0.13% 73
2020
Q1
Sell
-24,740
Closed -$3.61M 454
2019
Q4
$3.61M Buy
24,740
+2,021
+9% +$274K 0.15% 58
2019
Q3
$2.94M Buy
+22,719
New +$2.99M 0.14% 60
2019
Q2
Sell
-19,199
Closed -$2.67M 366
2019
Q1
$2.67M Buy
+19,199
New +$2.57M 0.15% 52
2017
Q3
Sell
-9,142
Closed -$1.22M 180
2017
Q2
$1.22M Buy
+9,142
New +$1.17M 0.13% 41
2016
Q3
Sell
-4,425
Closed -$537K 78
2016
Q2
$537K Buy
+4,425
New +$503K 0.09% 42

Other funds holding JNJ

Park Avenue Securities's JNJ Position: Q2 2026 in Review

Park Avenue Securities reduced its Johnson & Johnson (JNJ) stake by 3% in Q2 2026, selling an estimated $852K and leaving 119,431 shares worth $30.3M. The position accounts for 0.19% of the portfolio, ranked #92.

Park Avenue Securities first reported a position in JNJ in Q2 2016 and has held it in 30 quarters since. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Park Avenue Securities held 119,431 shares of Johnson & Johnson worth $30.3M as of Q2 2026.
  • Park Avenue Securities sold 3,656 Johnson & Johnson shares in Q2 2026, an estimated $852K.
  • Johnson & Johnson made up 0.19% of Park Avenue Securities's portfolio in Q2 2026, its #92 holding.
  • Park Avenue Securities first reported a position in Johnson & Johnson in Q2 2016 and has held it in 30 quarters since.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.